In this week’s episode of DeviceTalks Weekly the editorial team from MassDevice reviews the Medical Design & Outsourcing’s Women in Medtech issue bringing you insights through interviews with Katie Syzman, corporate VP and the GM of critical care at Edwards Lifesciences, Naomi Murray, Stryker’s director of advanced operations, and Patty Post, CEO of Startup Checkable Medical.
Szyman will share Edwards’ view of artificial intelligence. Murray will share her future vision on additive manufacturing while Post will reveal the lessons learned in her first post as startup CEO of a diagnostic company.
In our closing keynote conversation, Vijay Kumar, managing director at Evercore ISI, will explain why Exact Science’s acquisition of liquid biopsy company wasn’t exactly a surprise (though the $2 billion pricetag might have been.) He also assesses Boston Scientific’s COVID-19 comeback. What does the rise in cases mean for the company and the rest of medtech?
Chris Newmarker, executive editor of life sciences, delivers this week’s Newmarker’s Newsmakers which highlights reports on Abbott, Baxter, Intuitive Surgical and Siemens. Senior Editor Danielle Kirsh also is on hand to talk through MassDevice Big 100 report. Assistant editor Sean Whooley also joins the conversation.